Saturday, December 22, 2007 9:41:46 PM
WHO's there? WHO. WHO's who? A rat, that's WHO.
The facts: 1) The WHO has delayed a situation update about Pakistan, with the disease onset dates of the confirmed patients and the relationships of the patients to each other, and receptor binding domain changes in H5N1 sequences - something they never do. 2) The WHO sent a team of experts to Pakistan to help investigate the situation, and US Navy Medical Research Unit 3 (NAMRU-3) in Cairo has sent a portable laboratory. 3) The NAMRU unit sent samples of what they found to London even though this is unnecessary and means that they found receptor binding domain changes that they wanted London to review to determine if these changes are associated with receptor binding affinity changes (the last step before a pandemic). 4) New cases have been confirmed this month by NAMRU-3, which contradicts statements made yesterday by the Pakistan Ministry of Health (yeah, big surprise there). 5) "The delay in the WHO situation update again points toward serious issues in Pakistan, which may have generated the most sustained H5N1 transmission chain reported to date." Niman.
The WHO press releases are BS smoke and mirrors. The real question is why the BS?... Why the smoke and mirrors? There really is only one reason that I can even guess at. Control. It's no wonder the Indonesian Government does not want to release samples to the WHO.
To quote my other hero, Dr. Niman, "The lack of transparency increases pandemic concerns."
It's not just knocking at the door, my friend. It's already inside, sitting on the couch, having a sandwich and a coke watching the Patriots go 16 & 0.
Ismellarat10x
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM